Tirzepatide: Dual GIP/GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity. InaJEMD [Internet]. 2024 Sep. 3 [cited 2025 Aug. 3];1(2):96-110. Available from: https://inajemd.pbperkeni.or.id/index.php/journal/article/view/vol1-no2-section12